Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.
about
Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis.Iron deficiency anemia in chronic liver disease: etiopathogenesis, diagnosis and treatment.The Role of Iron and Iron Overload in Chronic Liver Disease.Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker.
P2860
Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.
@ast
Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.
@en
type
label
Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.
@ast
Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.
@en
prefLabel
Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.
@ast
Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.
@en
P2093
P2860
P1433
P1476
Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.
@en
P2093
Aggeliki Lyberopoulou
Asterios Saitis
Avgi Mamalaki
Eleni Kyratzopoulou
George K Koukoulis
George N Dalekos
Georgia Chachami
Kalliopi Zachou
Nikolaos K Gatselis
Petros Eliades
P2860
P304
P356
10.1371/JOURNAL.PONE.0135486
P407
P577
2015-08-13T00:00:00Z